OncoCyte Balance Sheet Health
Financial Health criteria checks 4/6
OncoCyte has a total shareholder equity of $9.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $70.2M and $60.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.36m |
| Equity | US$9.71m |
| Total liabilities | US$60.51m |
| Total assets | US$70.22m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7OC0's short term assets ($4.8M) do not cover its short term liabilities ($9.1M).
Long Term Liabilities: 7OC0's short term assets ($4.8M) do not cover its long term liabilities ($51.4M).
Debt to Equity History and Analysis
Debt Level: 7OC0 is debt free.
Reducing Debt: 7OC0 has no debt compared to 5 years ago when its debt to equity ratio was 2%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7OC0 has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 7OC0 is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.